It is of particular note that approximately 20% of tumours, which are initially negative for HER2, can become positive over time as they progress, mainly following endocrine treatment (Gutierrez et al. 2005, Priedigkeit et al. 2017, 2021). The gene discussed is ERBB2; the disease is neoplasm.